Hexarelin is a highly potent GHS-R1a agonist with the strongest GH-releasing punch of the GHRP family and almost no appetite effect. The same high binding affinity that makes it hit hard also makes it desensitize its own receptors faster than any other GHRP, which the source treats as its defining practical limit. Research also reports cardioprotective signaling alongside the GH release.
- The strongest GH-releasing peptide of the GHRP family, driven by unusually high GHS-R1a binding affinity.PubMed: hexarelin
- Minimal appetite effect compared with GHRP-6, which keeps hunger out of the picture as a confounder.PubMed: hexarelin
- Research reports cardioprotective signaling on top of the growth-hormone effect.PubMed: hexarelin
- Desensitization is the fastest of any GHRP, with extended exposure cutting response by 45% or more as receptors downregulate.researchdosing
- Ghrelin-type secretagogues produce a larger GH rise in female subjects, while male subjects reach the IGF-1 ceiling more readily.Span 2000